The DOI matches its Crossref record; 195 of the 195 references it cites were found in a registry or an index.
Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
Soda, M., Choi, Y. L., Enomoto, M., Takada, S., Yamashita, Y., Ishikawa, S., Fujiwara, S.-I., Watanabe, H., Kurashina, K., Hatanaka, H., et al. (2007) · Nature · doi:10.1038/nature05945 · Cited by 5,439
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Kwak, E. L., Bang, Y.-J., Camidge, D. R., Shaw, A. T., Solomon, B., Maki, R. G., Ou, S.-H. I., Dezube, B. J., Jänne, P. A., Costa, D. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006448 · Cited by 4,446
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer
Shaw, A. T., Kim, D.-W., Nakagawa, K., Seto, T., Crinó, L., Ahn, M.-J., De Pas, T., Besse, B., Solomon, B. J., Blackhall, F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214886 · Cited by 3,381
WHO Classification: Tumours of the Haematopoietic and Lymphoid Tissues (2008)
(2015) · Postgraduate Haematology · doi:10.1002/9781118853771.ch51 · Cited by 3,290
Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma
Morris, S. W., Kirstein, M. N., Valentine, M. B., Dittmer, K. G., Shapiro, D. N., Saltman, D. L., & Look, A. T. (1994) · Science · doi:10.1126/science.8122112 · Cited by 2,409
Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer
Rikova, K., Guo, A., Zeng, Q., Possemato, A., Yu, J., Haack, H., Nardone, J., Lee, K., Reeves, C., Li, Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.11.025 · Cited by 2,317
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
Yun, C.-H., Mengwasser, K. E., Toms, A. V., Woo, M. S., Greulich, H., Wong, K.-K., Meyerson, M., & Eck, M. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709662105 · Cited by 2,118
Maris, J. M., Hogarty, M. D., Bagatell, R., & Cohn, S. L. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60983-0 · Cited by 2,032
Recent Advances in Neuroblastoma
Maris, J. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0804577 · Cited by 1,983
Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
Shaw, A. T., Yeap, B. Y., Mino-Kenudson, M., Digumarthy, S. R., Costa, D. B., Heist, R. S., Solomon, B., Stubbs, H., Admane, S., McDermott, U., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.6993 · Cited by 1,870
Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
Heidorn, S. J., Milagre, C., Whittaker, S., Nourry, A., Niculescu-Duvas, I., Dhomen, N., Hussain, J., Reis-Filho, J. S., Springer, C. J., Pritchard, C., et al. (2010) · Cell · doi:10.1016/j.cell.2009.12.040 · Cited by 1,465
Identification of ALK as a major familial neuroblastoma predisposition gene
Mossé, Y. P., Laudenslager, M., Longo, L., Cole, K. A., Wood, A., Attiyeh, E. F., Laquaglia, M. J., Sennett, R., Lynch, J. E., Perri, P., et al. (2008) · Nature · doi:10.1038/nature07261 · Cited by 1,407
Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers
Katayama, R., Shaw, A. T., Khan, T. M., Mino-Kenudson, M., Solomon, B. J., Halmos, B., Jessop, N. A., Wain, J. C., Yeo, A. T., Benes, C., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003316 · Cited by 1,309
EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors
Choi, Y. L., Soda, M., Yamashita, Y., Ueno, T., Takashima, J., Nakajima, T., Yatabe, Y., Takeuchi, K., Hamada, T., Haruta, H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007478 · Cited by 1,189
The genetic landscape of high-risk neuroblastoma
Pugh, T. J., Morozova, O., Attiyeh, E. F., Asgharzadeh, S., Wei, J. S., Auclair, D., Carter, S. L., Cibulskis, K., Hanna, M., Kiezun, A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2529 · Cited by 1,186
Jemal, A., Clegg, L. X., Ward, E., Ries, L. A. G., Wu, X., Jamison, P. M., Wingo, P. A., Howe, H. L., Anderson, R. N., & Edwards, B. K. (2004) · Cancer · doi:10.1002/cncr.20288 · Cited by 1,140
Immunoaffinity profiling of tyrosine phosphorylation in cancer cells
Rush, J., Moritz, A., Lee, K. A., Guo, A., Goss, V. L., Spek, E. J., Zhang, H., Zha, X.-M., Polakiewicz, R. D., & Comb, M. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1046 · Cited by 1,124
Combinatorial drug therapy for cancer in the post-genomic era
Al-Lazikani, B., Banerji, U., & Workman, P. (2012) · Nature Biotechnology · doi:10.1038/nbt.2284 · Cited by 1,070
Doebele, R. C., Pilling, A. B., Aisner, D. L., Kutateladze, T. G., Le, A. T., Weickhardt, A. J., Kondo, K. L., Linderman, D. J., Heasley, L. E., Franklin, W. A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2906 · Cited by 1,063
Stein, H., Foss, H., Dürkop, H., Marafioti, T., Delsol, G., Pulford, K. A. F., Pileri, S. A., & Falini, B. (2000) · Blood · doi:10.1182/blood.v96.12.3681 · Cited by 949
Oncogenic mutations of ALK kinase in neuroblastoma
Chen, Y., Takita, J., Choi, Y. L., Kato, M., Ohira, M., Sanada, M., Wang, L., Soda, M., Kikuchi, A., Igarashi, T., et al. (2008) · Nature · doi:10.1038/nature07399 · Cited by 916
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Janoueix-Lerosey, I., Lequin, D., Brugières, L., Ribeiro, A., de Pontual, L., Combaret, V., Raynal, V., Puisieux, A., Schleiermacher, G., Pierron, G., et al. (2008) · Nature · doi:10.1038/nature07398 · Cited by 894
Activating mutations in ALK provide a therapeutic target in neuroblastoma
George, R. E., Sanda, T., Hanna, M., Fröhling, S., II, W. L., Zhang, J., Ahn, Y., Zhou, W., London, W. B., McGrady, P., et al. (2008) · Nature · doi:10.1038/nature07397 · Cited by 893
The anaplastic lymphoma kinase in the pathogenesis of cancer
Chiarle, R., Voena, C., Ambrogio, C., Piva, R., & Inghirami, G. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2291 · Cited by 882
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
Lipson, D., Capelletti, M., Yelensky, R., Otto, G., Parker, A., Jarosz, M., Curran, J. A., Balasubramanian, S., Bloom, T., Brennan, K. W., et al. (2012) · Nature Medicine · doi:10.1038/nm.2673 · Cited by 869
Savage, K. J., Harris, N. L., Vose, J. M., Ullrich, F., Jaffe, E. S., Connors, J. M., Rimsza, L., Pileri, S. A., Chhanabhai, M., Gascoyne, R. D., et al. (2008) · Blood · doi:10.1182/blood-2008-01-134270 · Cited by 863
Iwahara, T., Fujimoto, J., Wen, D., Cupples, R., Bucay, N., Arakawa, T., Mori, S., Ratzkin, B., & Yamamoto, T. (1997) · Oncogene · doi:10.1038/sj.onc.1200849 · Cited by 726
Takeuchi, K., Choi, Y. L., Togashi, Y., Soda, M., Hatano, S., Inamura, K., Takada, S., Ueno, T., Yamashita, Y., Satoh, Y., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3248 · Cited by 717
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
Lawrence, B., Perez-Atayde, A., Hibbard, M. K., Rubin, B. P., Dal Cin, P., Pinkus, J. L., Pinkus, G. S., Xiao, S., Yi, E. S., Fletcher, C. D. M., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64550-6 · Cited by 714
Mossé, Y. P., Lim, M. S., Voss, S. D., Wilner, K., Ruffner, K., Laliberte, J., Rolland, D., Balis, F. M., Maris, J. M., Weigel, B. J., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70095-0 · Cited by 712
Christensen, J. G., Zou, H. Y., Arango, M. E., Li, Q., Lee, J. H., McDonnell, S. R., Yamazaki, S., Alton, G. R., Mroczkowski, B., & Los, G. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0365 · Cited by 649
Mechanisms of Autoinhibition and STI-571/Imatinib Resistance Revealed by Mutagenesis of BCR-ABL
Azam, M., Latek, R. R., & Daley, G. Q. (2003) · Cell · doi:10.1016/s0092-8674(03)00190-9 · Cited by 613
A Novel ALK Secondary Mutation and EGFR Signaling Cause Resistance to ALK Kinase Inhibitors
Sasaki, T., Koivunen, J., Ogino, A., Yanagita, M., Nikiforow, S., Zheng, W., Lathan, C., Marcoux, J. P., Du, J., Okuda, K., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1340 · Cited by 597
Seto, T., Kiura, K., Nishio, M., Nakagawa, K., Maemondo, M., Inoue, A., Hida, T., Yamamoto, N., Yoshioka, H., Harada, M., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70142-6 · Cited by 575
Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors.
Griffin, C. A., Hawkins, A. L., Dvorak, C. C., Henkle, C., Ellingham, T. J., & Perlman, E. J. (1999) · PubMed · Cited by 571
ALK+ lymphoma: clinico-pathological findings and outcome.
Falini, B., Pileri, S. A., Zinzani, P. L., Carbone, A., Zagonel, V., Wolf‐Peeters, C. D., Verhoef, G. E. G., Menestrina, F., Todeschini, G., Paulli, M., et al. (1999) · PubMed · doi:10.1182/blood.v93.8.2697 · Cited by 560
Pulford, K. A. F., Lamant, L., Morris, S. W., Butler, L. H., Wood, K. M., Stroud, D., Delsol, G., & Mason, D. Y. (1997) · Blood · doi:10.1182/blood.v89.4.1394 · Cited by 557
Gascoyne, R. D., Aoun, P., Wu, D., Chhanabhai, M., Skinnider, B. F., Greiner, T. C., Morris, S. W., Connors, J. M., Vose, J. M., Viswanatha, D. S., et al. (1999) · Blood · doi:10.1182/blood.v93.11.3913 · Cited by 524
Morris, S. W., Naeve, C., Mathew, P., James, P. L., Kirstein, M. N., Cui, X., & Witte, D. P. (1997) · Oncogene · doi:10.1038/sj.onc.1201062 · Cited by 524
The significance of unstable chromosomes in colorectal cancer
Rajagopalan, H., Nowak, M. A., Vogelstein, B., & Lengauer, C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1165 · Cited by 502
Zebrafish pigmentation mutations and the processes of neural crest development
Kelsh, R. N., Brand, M., Jiang, Y.-J., Heisenberg, C.-P., Lin, S., Haffter, P., Odenthal, J., Mullins, M. C., Eeden, F. J. M. V., Furutani-Seiki, M., et al. (1996) · Development · doi:10.1242/dev.123.1.369 · Cited by 455
Anaplastic lymphoma kinase: signalling in development and disease
Palmer, R. H., Vernersson, E., Grabbe, C., & Hallberg, B. (2009) · Biochemical Journal · doi:10.1042/bj20090387 · Cited by 423
Self-citationTreatment of Non–Small-Cell Lung Cancer with Erlotinib or Gefitinib
Cataldo, V. D., Gibbons, D. L., Pérez-Soler, R., & Quintás-Cardama, A. (2011) · New England Journal of Medicine · doi:10.1056/nejmct0807960 · Cited by 418
Muramatsu, T. (2002) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a003231 · Cited by 405
Identification of Anaplastic Lymphoma Kinase as a Receptor for the Growth Factor Pleiotrophin
Stoica, G. E., Kuo, A., Aigner, A., Sunitha, I., Souttou, B., Malerczyk, C., Caughey, D. J., Wen, D., Karavanov, A., Riegel, A. T., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010660200 · Cited by 382
Shiota, M., Nakamura, S., Ichinohasama, R., Abe, M., Akagi, T., Takeshita, M., Mori, N., Fujimoto, J., Miyauchi, J., & Mikata, A. (1995) · Blood · doi:10.1182/blood.v86.5.1954.bloodjournal8651954 · Cited by 380
Activated ALK Collaborates with MYCN in Neuroblastoma Pathogenesis
Zhu, S., Lee, J.-S., Guo, F., Shin, J., Perez-Atayde, A. R., Kutok, J. L., Rodig, S. J., Neuberg, D. S., Helman, D., Feng, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.010 · Cited by 365
Fusion of the ALK Gene to the Clathrin Heavy Chain Gene, CLTC, in Inflammatory Myofibroblastic Tumor
Bridge, J. A., Kanamori, M., Ma, Z., Pickering, D., Hill, D. A., Lydiatt, W., Lui, M. Y., Colleoni, G. W. B., Antonescu, C. R., Ladanyi, M., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61711-7 · Cited by 359
Stoica, G. E., Kuo, A., Powers, C., Bowden, E. T., Sale, E. B., Riegel, A. T., & Wellstein, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205749200 · Cited by 357
Midkine and pleiotrophin in neural development and cancer
Kadomatsu, K., & Muramatsu, T. (2004) · Cancer Letters · doi:10.1016/s0304-3835(03)00450-6 · Cited by 354
Overall Genomic Pattern Is a Predictor of Outcome in Neuroblastoma
Janoueix-Lerosey, I., Schleiermacher, G., Michels, E., Mosseri, V., Ribeiro, A., Lequin, D., Vermeulen, J., Couturier, J., Peuchmaur, M., Valent, A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.0630 · Cited by 349
Sasaki, T., Okuda, K., Zheng, W., Butrynski, J., Capelletti, M., Wang, L., Gray, N. S., Wilner, K., Christensen, J. G., Demetri, G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2956 · Cited by 335
Sequist, L. V., Gettinger, S., Senzer, N. N., Martins, R. G., Jänne, P. A., Lilenbaum, R., Gray, J. E., Iafrate, A. J., Katayama, R., Hafeez, N., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.8338 · Cited by 330
The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma
Berry, T., Luther, W., Bhatnagar, N., Jamin, Y., Poon, E., Sanda, T., Pei, D., Sharma, B., Vetharoy, W. R., Hallsworth, A., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.001 · Cited by 326
Self-citationTyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis
Porter, A. C., & Vaillancourt, R. R. (1998) · Oncogene · doi:10.1038/sj.onc.1202171 · Cited by 320
Exon Array Profiling Detects EML4-ALK Fusion in Breast, Colorectal, and Non–Small Cell Lung Cancers
Lin, E., Li, L., Guan, Y., Soriano, R., Rivers, C. S., Mohan, S., Pandita, A., Tang, J., & Modrusan, Z. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0522 · Cited by 302
E2F1 represses β-catenin transcription and is antagonized by both pRB and CDK8
Morris, E. J., Ji, J.-Y., Yang, F., Di Stefano, L., Herr, A., Moon, N.-S., Kwon, E.-J., Haigis, K. M., Näär, A. M., & Dyson, N. J. (2008) · Nature · doi:10.1038/nature07310 · Cited by 297
Cools, J., Włodarska, I., Somers, R., et al. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10033 · Cited by 292
Hernández, L., Pinyol, M., Hernández, S., Beà, S., Pulford, K., Rosenwald, A., Lamant, L., Falini, B., Ott, G., Mason, D. Y., et al. (1999) · Blood · doi:10.1182/blood.v94.9.3265 · Cited by 287
Carén, H., Abel, F., Kogner, P., & Martinsson, T. (2008) · Biochemical Journal · doi:10.1042/bj20081834 · Cited by 280
Fusion of ALK to the Ran‐binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor
Ma, Z., Hill, D. A., Collins, M. H., Morris, S. W., Sumegi, J., Zhou, M., Zuppan, C., & Bridge, J. A. (2003) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.10177 · Cited by 280
De Brouwer, S., De Preter, K., Kumps, C., Zabrocki, P., Porcu, M., Westerhout, E. M., Lakeman, A., Vandesompele, J., Hoebeeck, J., Van Maerken, T., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2660 · Cited by 279
Togashi, Y., Soda, M., Sakata, S., Sugawara, E., Hatano, S., Asaka, R., Nakajima, T., Mano, H., & Takeuchi, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031323 · Cited by 267
Pathobiology of ALK+ anaplastic large-cell lymphoma
Amin, H. M., & Lai, R. (2007) · Blood · doi:10.1182/blood-2007-04-060715 · Cited by 267
Defining the conserved internal architecture of a protein kinase
Kornev, A. P., & Taylor, S. S. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.10.017 · Cited by 266
Anaplastic Lymphoma Kinase Spares Organ Growth during Nutrient Restriction in Drosophila
Cheng, L. Y., Bailey, A. P., Leevers, S. J., Ragan, T. J., Driscoll, P. C., & Gould, A. P. (2011) · Cell · doi:10.1016/j.cell.2011.06.040 · Cited by 252
Shiota, M., Fujimoto, J., Semba, T., Satoh, H., Yamamoto, T. S., & Mori, S. (1994) · PubMed · Cited by 246
Renal cell carcinoma with novel VCL–ALK fusion: new representative of ALK-associated tumor spectrum
Debelenko, L. V., Raimondi, S. C., Daw, N., Shivakumar, B. R., Huang, D., Nelson, M., & Bridge, J. A. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.213 · Cited by 244
Protein kinase signaling networks in cancer
Brognard, J., & Hunter, T. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.012 · Cited by 240
Differential Inhibitor Sensitivity of Anaplastic Lymphoma Kinase Variants Found in Neuroblastoma
Bresler, S. C., Wood, A. C., Haglund, E. A., Courtright, J., Belcastro, L. T., Plegaria, J. S., Cole, K., Toporovskaya, Y., Zhao, H., Carpenter, E. L., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002950 · Cited by 237
An SCF-like ubiquitin ligase complex that controls presynaptic differentiation
Liao, E. H., Hung, W., Abrams, B., & Zhen, M. (2004) · Nature · doi:10.1038/nature02647 · Cited by 233
Sydor, J. R., Normant, E., Pien, C. S., Porter, J. R., Ge, J., Grenier, L., Pak, R. H., Ali, J. A., Dembski, M. S., Hudak, J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608372103 · Cited by 231
Expression of the ALK Tyrosine Kinase Gene in Neuroblastoma
Lamant, L., Pulford, K., Bischof, D., Morris, S. W., Mason, D. Y., Delsol, G., & Mariamé, B. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65042-0 · Cited by 226
Hölzel, M., Huang, S., Koster, J., Øra, I., Lakeman, A., Caron, H., Nijkamp, W., Xie, J., Callens, T., Asgharzadeh, S., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.004 · Cited by 224
Ou, S.-H. I., Bartlett, C. H., Mino-Kenudson, M., Cui, J., & Iafrate, A. J. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0311 · Cited by 224
Kris, M. G., Johnson, B. E., Kwiatkowski, D. J., Iafrate, A. J., Wistuba, I. I., Aronson, S. L., Engelman, J. A., Shyr, Y., Khuri, F. R., Rudin, C. M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.29.15_suppl.cra7506 · Cited by 213
Myc proteins as therapeutic targets
Gustafson, W. C., & Weiss, W. A. (2010) · Oncogene · doi:10.1038/onc.2009.512 · Cited by 204
Chaft, J. E., Arcila, M. E., Paik, P. K., Lau, C., Riely, G. J., Pietanza, M. C., Zakowski, M. F., Rusch, V., Sima, C. S., Ladanyi, M., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0692 · Cited by 202
Chesler, L., Schlieve, C., Goldenberg, D. D., Kenney, A., Kim, G., McMillan, A., Matthay, K. K., Rowitch, D., & Weiss, W. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2769 · Cited by 202
Jelly belly protein activates the receptor tyrosine kinase Alk to specify visceral muscle pioneers
Lee, H.-H., Norris, A., Weiss, J. B., & Frasch, M. (2003) · Nature · doi:10.1038/nature01916 · Cited by 194
Anaplastic Thyroid Cancers Harbor Novel Oncogenic Mutations of the ALK Gene
Murugan, A. K., & Xing, M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4041 · Cited by 193
ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK Inhibitors
Heuckmann, J. M., Hölzel, M., Sos, M. L., Heynck, S., Balke-Want, H., Koker, M., Peifer, M., Weiss, J., Lovly, C. M., Grütter, C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1648 · Cited by 191
Ge, J., Normant, E., Porter, J. R., Ali, J. A., Dembski, M. S., Gao, Y., Georges, A. T., Grenier, L., Pak, R. H., Patterson, J., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0603116 · Cited by 191
ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma
De Paepe, P., Baens, M., van Krieken, H., Verhasselt, B., Stul, M., Simons, A., Poppe, B., Laureys, G., Brons, P., Vandenberghe, P., et al. (2003) · Blood · doi:10.1182/blood-2003-04-1050 · Cited by 191
Bilsland, J. G., Wheeldon, A., Mead, A., Znamenskiy, P., Almond, S., Waters, K. A., Thakur, M., Beaumont, V., Bonnert, T. P., Heavens, R., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301446 · Cited by 188
Matsuyama, H., Suzuki, H. I., Nishimori, H., Noguchi, M., Yao, T., Komatsu, N., Mano, H., Sugimoto, K., & Miyazono, K. (2011) · Blood · doi:10.1182/blood-2011-05-354654 · Cited by 182
Ishihara, T., Iino, Y., Mohri, A., Mori, I., Gengyo-Ando, K., Mitani, S., & Katsura, I. (2002) · Cell · doi:10.1016/s0092-8674(02)00748-1 · Cited by 182
Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain
Lee, C. C., Jia, Y., Li, N., Sun, X., Ng, K., Ambing, E., Gao, M.-Y., Hua, S., Chen, C., Kim, S., et al. (2010) · Biochemical Journal · doi:10.1042/bj20100609 · Cited by 182
Targeted Expression of Mutated ALK Induces Neuroblastoma in Transgenic Mice
Heukamp, L. C., Thor, T., Schramm, A., De Preter, K., Kumps, C., De Wilde, B., Odersky, A., Peifer, M., Lindner, S., Spruessel, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003967 · Cited by 181
Jeb signals through the Alk receptor tyrosine kinase to drive visceral muscle fusion
Englund, C., Lorén, C. E., Grabbe, C., Varshney, G. K., Deleuil, F., Hallberg, B., & Palmer, R. H. (2003) · Nature · doi:10.1038/nature01950 · Cited by 179
Self-citationCharacterization of the expression of the ALK receptor tyrosine kinase in mice
Vernersson, E., Khoo, N. K. S., Henriksson, M. L., Roos, G., Palmer, R. H., & Hallberg, B. (2006) · Gene Expression Patterns · doi:10.1016/j.modgep.2005.11.006 · Cited by 178
Self-citationTargeting ALK in neuroblastoma—preclinical and clinical advancements
Carpenter, E. L., & Mossé, Y. P. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.72 · Cited by 177
Colleoni, G. W. B., Bridge, J. A., Garicochea, B., Liu, J., Filippa, D. A., & Ladanyi, M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64945-0 · Cited by 174
Crystal Structures of Anaplastic Lymphoma Kinase in Complex with ATP Competitive Inhibitors
Bossi, R. T., Saccardo, M. B., Ardini, E., Menichincheri, M., Rusconi, L., Magnaghi, P., Orsini, P., Avanzi, N., Borgia, A. L., Nesi, M., et al. (2010) · Biochemistry · doi:10.1021/bi1005514 · Cited by 173
Passoni, L., Longo, L., Collini, P., Coluccia, A. M. L., Bozzi, F., Podda, M., Gregorio, A., Gambini, C., Garaventa, A., Pistoia, V., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4419 · Cited by 173
Inhibition of ALK Signaling for Cancer Therapy
Mossé, Y. P., Wood, A., & Maris, J. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2762 · Cited by 172
ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth
Motegi, A., Fujimoto, J., Kotani, M., Sakuraba, H., & Yamamoto, T. (2004) · Journal of Cell Science · doi:10.1242/jcs.01183 · Cited by 167
Leukocyte Tyrosine Kinase Functions in Pigment Cell Development
Lopes, S. S., Yang, X., Müller, J., Carney, T. J., McAdow, A. R., Rauch, G.-J., Jacoby, A. S., Hurst, L. D., Delfino-Machín, M., Haffter, P., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000026 · Cited by 163
Debelenko, L. V., Arthur, D. C., Pack, S. D., Helman, L. J., Schrump, D. S., & Tsokos, M. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000088856.49388.ea · Cited by 163
Piva, R., Pellegrino, E., Mattioli, M., Agnelli, L., Lombardi, L., Boccalatte, F., Costa, G., Ruggeri, B. A., Cheng, M., Chiarle, R., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29401 · Cited by 163
Bazigou, E., Apitz, H., Johansson, J., Lorén, C. E., Hirst, E. M. A., Chen, P.-L., Palmer, R. H., & Salecker, I. (2007) · Cell · doi:10.1016/j.cell.2007.02.024 · Cited by 161
Self-citationIncreased ALK Gene Copy Number and Amplification are Frequent in Non-small Cell Lung Cancer
Salido, M., Pijuan, L., Martínez-Avilés, L., Galván, A. B., Cañadas, I., Rovira, A., Zanui, M., Martínez, A., Longarón, R., Sole, F., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181fb7cd6 · Cited by 160
Moog-Lutz, C., Degoutin, J., Gouzi, J. Y., Frobert, Y., Carvalho, N. B.-D., Bureau, J., Créminon, C., & Vigny, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501972200 · Cited by 158
Sugawara, E., Togashi, Y., Kuroda, N., Sakata, S., Hatano, S., Asaka, R., Yuasa, T., Yonese, J., Kitagawa, M., Mano, H., et al. (2012) · Cancer · doi:10.1002/cncr.27391 · Cited by 151
Sukov, W. R., Hodge, J. C., Lohse, C. M., Akre, M. K., Leibovich, B. C., Thompson, R. H., & Cheville, J. C. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.107 · Cited by 151
Normant, E., Paez, G., West, K. A., Lim, A. R., Slocum, K. L., Tunkey, C., McDougall, J., Wylie, A. A., Robison, K. E., Caliri, K., et al. (2011) · Oncogene · doi:10.1038/onc.2010.625 · Cited by 145
Pérez‐Piñera, P., Zhang, W., Chang, Y., Vega, J. A., & Deuel, T. F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704505200 · Cited by 143
Insulin-like signaling and the neural circuit for integrative behavior in C. elegansPreprint
Kodama, E., Kuhara, A., Mohri‐Shiomi, A., Kimura, K. D., Okumura, M., Tomioka, M., Iino, Y., & Mori, I. (2006) · Genes & Development · doi:10.1101/gad.1479906 · Cited by 142
Jazii, F. R. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i44.7104 · Cited by 141
Non‐muscle myosin heavy chain (MYH9): A new partner fused to ALK in anaplastic large cell lymphoma
Lamant, L., Gascoyne, R. D., Duplantier, M.-M., Armstrong, F., Raghab, A., Chhanabhai, M., Rajcan‐Separovic, E., Raghab, J., Delsol, G., & Espinos, E. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10232 · Cited by 141
Kris, M. G., Johnson, B. E., Kwiatkowski, D. J., Iafrate, A. J., Wistuba, I. I., Aronson, S. L., Engelman, J. A., Shyr, Y., Khuri, F. R., Rudin, C. M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.29.18_suppl.cra7506 · Cited by 141
Anaplastic lymphoma kinase in human cancer
Barreca, A., Lasorsa, E., Riera, L., Machiorlatti, R., Piva, R., Ponzoni, M., Kwee, I., Bertoni, F., Piccaluga, P. P., Pileri, S. A., et al. (2011) · Journal of Molecular Endocrinology · doi:10.1530/jme-11-0004 · Cited by 140
Proteomic profiling of proteins dysregulted in Chinese esophageal squamous cell carcinoma
Du, X., Hu, H., Lin, D., Xia, S.-H., Shen, X., Zhang, Y., Luo, M., Feng, Y., Cai, Y., Xu, X., et al. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0159-4 · Cited by 136
Camidge, D. R., Bang, Y., Kwak, E. L., Shaw, A. T., Iafrate, A. J., Maki, R. G., Solomon, B., Ou, S.-H. I., Salgia, R., Wilner, K. D., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.29.15_suppl.2501 · Cited by 134
Bonvini, P., Gastaldi, T., Falini, B., & Rosolen, A. (2002) · PubMed · Cited by 130
The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination
Chiarle, R., Martinengo, C., Mastini, C., Ambrogio, C., d’Escamard, V., Forni, G., & Inghirami, G. (2008) · Nature Medicine · doi:10.1038/nm1769 · Cited by 129
Armstrong, F., Duplantier, M.-M., Trempat, P., Hiéblot, C., Lamant, L., Espinos, E., Racaud‐Sultan, C., Allouche, M., Campo, E., Delsol, G., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207813 · Cited by 129
Desjobert, C., Renalier, M.-H., Bergalet, J., Dejean, E., Joseph, N., Kruczynski, A., Soulier, J., Espinos, E., Meggetto, F., Cavaillé, J., et al. (2011) · Blood · doi:10.1182/blood-2010-09-301994 · Cited by 127
Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor
Panagopoulos, I., Nilsson, T., Domanski, H. A., Isaksson, M., Lindblom, P., Mertens, F., & Mandahl, N. (2005) · International Journal of Cancer · doi:10.1002/ijc.21490 · Cited by 126
Expression and functional analysis of the anaplastic lymphoma kinase (ALK) gene in tumor cell lines
Dirks, W. G., Fähnrich, S., Lis, Y., Becker, E., MacLeod, R. A. F., & Drexler, H. G. (2002) · International Journal of Cancer · doi:10.1002/ijc.10435 · Cited by 125
Identification of Anaplastic Lymphoma Kinase as a Potential Therapeutic Target in Ovarian Cancer
Ren, H., Tan, Z., Zhu, X., Crosby, K., Haack, H., Ren, J., Beausoleil, S. A., Moritz, A., Innocenti, G., Rush, A. J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3931 · Cited by 124
Lorén, C. E., Englund, C., Grabbe, C., Hallberg, B., Hunter, T. R., & Palmer, R. H. (2003) · EMBO Reports · doi:10.1038/sj.embor.embor897 · Cited by 123
Self-citationSchönherr, C., Ruuth, K., Kamaraj, S., Wang, C.-L., Yang, H.-L., Combaret, V., Djos, A., Martinsson, T., Christensen, J. G., Palmer, R. H., et al. (2012) · Oncogene · doi:10.1038/onc.2012.12 · Cited by 122
Self-citationIdentification of recurrent FGFR3 fusion genes in lung cancer through kinome‐centred RNA sequencing
Majewski, I. J., Mittempergher, L., Davidson, N., Bosma, A. R., Willems, S. M., Horlings, H. M., de Rink, I., Greger, L., Hooijer, G. K. J., Peters, D. D. G. C., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4209 · Cited by 119
Miyake, I., Hakomori, Y., Shinohara, A., Gamou, T., Saito, M., Iwamatsu, A., & Sakai, R. (2002) · Oncogene · doi:10.1038/sj.onc.1205735 · Cited by 116
Shinkai, Y., Yamamoto, Y., Fujiwara, M., Tabata, T., Murayama, T., Hirotsu, T., Ikeda, D. D., Tsunozaki, M., Iino, Y., Bargmann, C. I., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4691-10.2011 · Cited by 114
Takeuchi, K., Soda, M., Togashi, Y., Sugawara, E., Hatano, S., Asaka, R., Okumura, S., Nakagawa, K., Mano, H., & Ishikawa, Y. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0063 · Cited by 114
Identification of NPM-ALK interacting proteins by tandem mass spectrometry
Crockett, D. K., Lin, Z., Elenitoba‐Johnson, K. S. J., & Lim, M. S. (2004) · Oncogene · doi:10.1038/sj.onc.1207398 · Cited by 113
Mourali, J., Bénard, A., Lourenço, F. C., Monnet, C., Greenland, C., Moog‐Lutz, C., Racaud‐Sultan, C., Gonzalez‐Dunia, D., Vigny, M., Mehlen, P., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01515-05 · Cited by 113
Lorén, C. E., Scully, A. L., Grabbe, C., Edeen, P. T., Thomas, J. B., McKeown, M., Hunter, T. R., & Palmer, R. H. (2001) · Genes to Cells · doi:10.1046/j.1365-2443.2001.00440.x · Cited by 111
Self-citationDejean, E., Renalier, M.-H., Foisseau, M., Agirre, X., Joseph, N., Silva, G. R. D. P., Saati, T. A., Soulier, J., Desjobert, C., Lamant, L., et al. (2011) · Leukemia · doi:10.1038/leu.2011.168 · Cited by 111
Identification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma
Takeuchi, K., Soda, M., Togashi, Y., Ota, Y., Sekiguchi, Y., Hatano, S., Asaka, R., Noguchi, M., & Mano, H. (2010) · Haematologica · doi:10.3324/haematol.2010.033514 · Cited by 110
Weiss, J. B., Xue, C., Benice, T. S., Xue, L., Morris, S. W., & Raber, J. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.10.024 · Cited by 108
Diversity of Genomic Breakpoints in TFG-ALK Translocations in Anaplastic Large Cell Lymphomas
Hernández, L., Beà, S., Bellosillo, B., Pinyol, M., Falini, B., Carbone, A., Ott, G., Rosenwald, A., Fernández, A., Pulford, K. A. F., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62574-6 · Cited by 107
Schulte, J. H., Bachmann, H. S., Brockmeyer, B., Preter, K. D., Oberthür, A., Ackermann, S., Kahlert, Y., Pajtler, K. W., Theißen, J., Westermann, F., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2809 · Cited by 107
Staber, P. B., Vesely, P. W., Haq, N., Ott, R. G., Funato, K., Bambach, I., Fuchs, C. D., Schauer, S., Linkesch, W., Hrzenjak, A., et al. (2007) · Blood · doi:10.1182/blood-2007-02-071258 · Cited by 107
The Receptor Tyrosine Kinase Alk Controls Neurofibromin Functions in Drosophila Growth and Learning
Gouzi, J. Y., Moressis, A., Walker, J. A., Apostolopoulou, A. A., Palmer, R. H., Bernards, A., & Skoulakis, E. M. C. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002281 · Cited by 106
Self-citationAn Evolutionary Conserved Role for Anaplastic Lymphoma Kinase in Behavioral Responses to Ethanol
Lasek, A. W., Lim, J. P., Kliethermes, C. L., Berger, K. H., Joslyn, G., Brush, G., Xue, L., Robertson, M. A., Moore, M. S., VRANIZAN, K. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022636 · Cited by 104
ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions
Roosbroeck, K. V., Cools, J., Dierickx, D., Thomas, J., Vandenberghe, P., Stul, M. S., Delabie, J., Wolf‐Peeters, C. D., Marynen, P., & Włodarska, I. (2010) · Haematologica · doi:10.3324/haematol.2009.014761 · Cited by 104
Voena, C., Conte, C., Ambrogio, C., Erba, E. B., Boccalatte, F. E., Mohammed, S., Jensen, O. N., Palestro, G., Inghirami, G., & Chiarle, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4350 · Cited by 103
Jung, Y., Kim, P., Jung, Y., Keum, J., Kim, S., Choi, Y. S., Do, I., Lee, J., Choi, S., Kim, S., et al. (2012) · Genes Chromosomes and Cancer · doi:10.1002/gcc.21945 · Cited by 95
Weickhardt, A. J., Rothman, M. S., Salian‐Mehta, S., Kiseljak‐Vassiliades, K., Oton, A. B., Doebele, R. C., Wierman, M. E., & Camidge, D. R. (2012) · Cancer · doi:10.1002/cncr.27450 · Cited by 92
Weiss, J. B., Suyama, K. L., Lee, H., & Scott, M. P. (2001) · Cell · doi:10.1016/s0092-8674(01)00540-2 · Cited by 91
Weickhardt, A. J., Aisner, D. L., Franklin, W. A., Varella‐Garcia, M., Doebele, R. C., & Camidge, D. R. (2012) · Cancer · doi:10.1002/cncr.27913 · Cited by 88
Activating ALK mutations found in neuroblastoma are inhibited by Crizotinib and NVP-TAE684
Schönherr, C., Ruuth, K., Yamazaki, Y., Eriksson, T., Christensen, J. G., Palmer, R. H., & Hallberg, B. (2011) · Biochemical Journal · doi:10.1042/bj20101796 · Cited by 87
Self-citationNIPA Defines an SCF-Type Mammalian E3 Ligase that Regulates Mitotic Entry
Bassermann, F. C., von Klitzing, C., Münch, S., Bai, R.-Y., Kawaguchi, H., Morris, S. W., Peschel, C., & Duyster, J. (2005) · Cell · doi:10.1016/j.cell.2005.04.034 · Cited by 84
Tartari, C. J., Gunby, R. H., Coluccia, A. M. L., Sottocornola, R., Cimbro, B., Scapozza, L., Donella‐Deana, A., Pinna, L. A., & Gambacorti-Passerini, C. B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706067200 · Cited by 84
Martinsson, T., Eriksson, T., Abrahamsson, J., Carén, H., Hansson, M., Kogner, P., Kamaraj, S., Schönherr, C., Weinmar, J., Ruuth, K., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2366 · Cited by 84
Self-citationp130Cas mediates the transforming properties of the anaplastic lymphoma kinase
Ambrogio, C., Voena, C., Manazza, A. D., Piva, R., Riera, L., Barberis, L., Costa, C., Tarone, G., Defilippi, P., Hirsch, E., et al. (2005) · Blood · doi:10.1182/blood-2005-03-1204 · Cited by 84
Reiner, D. J., Ailion, M., Thomas, J. H., & Meyer, B. J. (2008) · Current Biology · doi:10.1016/j.cub.2008.06.060 · Cited by 82
Yao, S., Cheng, M. M., Zhang, Q., Wasik, M. A., Kelsh, R. N., & Winkler, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063757 · Cited by 79
Stute, C., Schimmelpfeng, K., Renkawitz‐Pohl, R., Palmer, R. H., & Holz, A. (2004) · Development · doi:10.1242/dev.00972 · Cited by 73
Self-citationColomba, A., Courilleau, D., Ramel, D., Billadeau, D. D., Espinos, E., Delsol, G., Payrastre, B., & Gaits‐Iacovoni, F. (2007) · Oncogene · doi:10.1038/sj.onc.1210921 · Cited by 71
Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma
Carpenter, E. L., Haglund, E. A., Mace, E. M., Deng, D., Martínez, D., Wood, A., Chow, A. K., Weiser, D. A., Belcastro, L. T., Winter, C. L., et al. (2012) · Oncogene · doi:10.1038/onc.2011.647 · Cited by 70
Rohrbough, J. C., & Broadie, K. S. (2010) · Development · doi:10.1242/dev.047878 · Cited by 67
Cazes, A., Louis‐Brennetot, C., Mazot, P., Dingli, F., Lombard, B., Boeva, V., Daveau, R., Cappo, J., Combaret, V., Schleiermacher, G., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1242 · Cited by 67
Crizotinib — Latest Champion in the Cancer Wars?
Hallberg, B., & Palmer, R. H. (2010) · New England Journal of Medicine · doi:10.1056/nejme1010404 · Cited by 66
Self-citationMathivet, T., Mazot, P., & Vigny, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.07.011 · Cited by 65
Ambrogio, C., Voena, C., Manazza, A. D., Martinengo, C., Costa, C., Kirchhausen, T. L., Hirsch, E., Inghirami, G., & Chiarle, R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2568 · Cited by 65
The proteomic signature of NPM/ALK reveals deregulation of multiple cellular pathways
Lim, M. S., Carlson, M. L., Crockett, D. K., Fillmore, G. C., Abbott, D. R., Elenitoba-Johnson, O. F., Tripp, S. R., Rassidakis, G. Z., Medeiros, L. J., Szankasi, P., et al. (2009) · Blood · doi:10.1182/blood-2009-02-204735 · Cited by 61
Aberrant activation of ALK kinase by a novel truncated form ALK protein in neuroblastoma
Okubo, J., Takita, J., Chen, Y., Oki, K., Nishimura, R., Kato, M., Sanada, M., Hiwatari, M., Hayashi, Y., Igarashi, T., et al. (2012) · Oncogene · doi:10.1038/onc.2011.616 · Cited by 60
Chand, D., Yamazaki, Y., Ruuth, K., Schönherr, C., Martinsson, T., Kogner, P., Attiyeh, E. F., Maris, J. M., Morozova, O., Marra, M. A., et al. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.010348 · Cited by 60
Self-citationHurley, S. P., Clary, D. O., Copié, V., & Lefcort, F. B. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20887 · Cited by 59
ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome
de l’Enfant, O. B. O. T. C. N. O. T. S. F. D. C., Bourdeaut, F., Ferrand, S., Brugières, L., Hilbert, M., Ribeiro, A., Lacroix, L., Bénard, J., Combaret, V., Michon, J. M., et al. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.195 · Cited by 58
MicroRNA 96 Is a Post-Transcriptional Suppressor of Anaplastic Lymphoma Kinase Expression
Vishwamitra, D., Li, Y., Wilson, D., Manshouri, R., Curry, C. V., Shi, B., Tang, X., Sheehan, A. M., Wistuba, I. I., Shi, P., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.01.008 · Cited by 58
Ouyang, T., Bai, R.-Y., Bassermann, F. C., von Klitzing, C., Klümpen, S., Miething, C., Morris, S. W., Peschel, C., & Duyster, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300883200 · Cited by 57
Degoutin, J. L., Carvalho, N. B.-D., Cifuentes-Díaz, C., & Vigny, M. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06593.x · Cited by 57
Wang, Y., Tu, P., Lin, K., Lin, S., Ko, J., & Jou, Y. (2011) · Neoplasia · doi:10.1593/neo.11222 · Cited by 56
Epstein, L. F., Chen, H., Emkey, R., & Whittington, D. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.391425 · Cited by 49
Siebert, R., Gesk, S., Harder, L., et al. (1999) · PubMed · doi:10.1182/blood.v94.10.3614.422a38e_3614_3617 · Cited by 49
Chi, C. A., Clark, D. A., Lee, S. J., Biron, D., Luo, L., Gabel, C. V., Brown, J. W., Sengupta, P., & Samuel, A. D. T. (2007) · Journal of Experimental Biology · doi:10.1242/jeb.006551 · Cited by 44
Barouch‐Bentov, R., Che, J., Lee, C. C., Yang, Y., Herman, A. E., Jia, Y., Velentza, A. V., Watson, J., Sternberg, L., Kim, S., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2008.12.024 · Cited by 42
Hyperactivated STAT3 in ALK–positive diffuse large B-cell lymphoma with clathrin-ALK fusion
Momose, S., Tamaru, J., Kishi, H., Mikata, I., Mori, M., Toyozumi, Y., & Itoyama, S. (2008) · Human Pathology · doi:10.1016/j.humpath.2008.06.009 · Cited by 39
The Neuroblastoma ALK(I1250T) Mutation Is a Kinase-Dead RTK In Vitro and In Vivo
Schönherr, C., Ruuth, K., Eriksson, T., Yamazaki, Y., Ottmann, C., Combaret, V., Vigny, M., Kamaraj, S., Palmer, R. H., & Hallberg, B. (2011) · Translational Oncology · doi:10.1593/tlo.11139 · Cited by 38
Self-citationNPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma
Galietta, A., Gunby, R. H., Redaelli, S., Stano, P., Carniti, C., Bachi, A., Tucker, P. W., Tartari, C. J., Huang, C.-J., Colombo, E., et al. (2007) · Blood · doi:10.1182/blood-2006-01-028647 · Cited by 38
Lai, M. B., Bhardwaj, V., Lai, J. C. K., et al. (2011) · Cancer Research · doi:10.1158/1538-7445.am2011-4403 · Cited by 38
Oncogenic kinase NPM/ALK induces expression of HIF1α mRNA
Marzec, M., Liu, X., Wong, W. J., Yang, Y., Pasha, T. L., Kantekure, K., Zhang, P., Woetmann, A., Cheng, M. M., Ødum, N., et al. (2010) · Oncogene · doi:10.1038/onc.2010.505 · Cited by 37
The bHLH transcription factor Hand is regulated by Alk in the Drosophila embryonic gut
Varshney, G. K., & Palmer, R. H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.117 · Cited by 37
Self-citationInvolvement of genes required for synaptic function in aging control in C. elegans
Shen, L., Wang, Y., & Wang, D. (2007) · Neuroscience Bulletin · doi:10.1007/s12264-007-0003-4 · Cited by 31
Domain-specific function of ShcC docking protein in neuroblastoma cells
Miyake, I., Hakomori, Y., Misu, Y., Nakadate, H., Matsuura, N., Sakamoto, M., & Sakai, R. (2005) · Oncogene · doi:10.1038/sj.onc.1208523 · Cited by 31
Drosophila Anaplastic Lymphoma Kinase regulates Dpp signalling in the developing embryonic gut
Shirinian, M., Varshney, G. K., Lorén, C. E., Grabbe, C., & Palmer, R. H. (2007) · Differentiation · doi:10.1111/j.1432-0436.2006.00148.x · Cited by 31
Self-citationAnaplastic lymphoma kinase as a therapeutic target
Kruczynski, A., Delsol, G., Laurent, C., Brousset, P., & Lamant, L. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.719498 · Cited by 30
Pearson, J. D., Lee, J. K. H., Bacani, J. T. C., Lai, R. L., & Ingham, R. J. (2011) · PubMed Central · Cited by 28
Dupuis-Coronas, S., Lagarrigue, F., Ramel, D., Chicanne, G., Saland, E., Gaits‐Iacovoni, F., Payrastre, B., & Tronchère, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.227512 · Cited by 28
Rohrbough, J. C., Kent, K. S., Broadie, K. S., & Weiss, J. B. (2012) · Developmental Neurobiology · doi:10.1002/dneu.22056 · Cited by 28
ALK and NSCLC: Targeted therapy with ALK inhibitors
Hallberg, B., & Palmer, R. H. (2011) · F1000 Medicine Reports · doi:10.3410/m3-21 · Cited by 25
Self-citationFusion Tyrosine Kinase NPM-ALK Deregulates MSH2 and Suppresses DNA Mismatch Repair Function
Young, L. C., Bone, K. M., Wang, P., Wu, F., Adam, B., Hegazy, S. A., Gélébart, P., Holovati, J. L., Li, L., Andrew, S. E., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.045 · Cited by 17
A Simple, Highly Visual in Vivo Screen for Anaplastic Lymphoma Kinase Inhibitors
Rodrigues, F. S. L. M., Yang, X., Nikaido, M., Liu, Q., & Kelsh, R. N. (2012) · ACS Chemical Biology · doi:10.1021/cb300361a · Cited by 15
Assessment of the transforming potential of novel anaplastic lymphoma kinase point mutants
McDuff, F. K. E., Lim, S., Dalbay, M. T., & Turner, S. D. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.21836 · Cited by 12
Yan, X., Kennedy, C. R., Tilkens, S. B., Wiedemeier, O., Guan, H., Park, J., & Chan, A. M.-L. (2011) · Genes & Cancer · doi:10.1177/1947601911416003 · Cited by 12
Cited by
Hida, T., Nokihara, H., Kondo, M., Kim, Y. H., Azuma, K., Seto, T., Takiguchi, Y., Nishio, M., Yoshioka, H., Imamura, F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30565-2 · Cited by 911
Targeting ALK: Precision Medicine Takes on Drug Resistance
Lin, J. J., Riely, G. J., & Shaw, A. T. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1123 · Cited by 522
Camidge, D. R., Dziadziuszko, R., Peters, S., Mok, T., Noe, J., Nowicka, M., Gadgeel, S. M., Cheema, P., Pavlakis, N., de Marinis, F., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.03.007 · Cited by 490
The landscape and therapeutic relevance of cancer-associated transcript fusions
Yoshihara, K., Wang, Q., Torres-Garcia, W., Zheng, S., Vegesna, R., Kim, H., & Verhaak, R. G. W. (2015) · Oncogene · doi:10.1038/onc.2014.406 · Cited by 450
The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer
Hsu, J. L., & Hung, M.-C. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9649-6 · Cited by 445
Metadata
- Authors
- Hallberg, B., & Palmer, R. H.
- Venue
- Nature Reviews Cancer
- Published
- 2013-09-24
- Volume
- 13
- Issue
- 10
- Pages
- 685-700
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2021876472
- Cited by
- 645
- References
- 195
- FWCI
- 8.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.